Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
3(19%)
Results Posted
33%(2 trials)
Terminated
1(6%)

Phase Distribution

Ph early_phase_1
1
6%
Ph not_applicable
2
13%
Ph phase_1
1
6%
Ph phase_4
7
44%
Ph phase_3
2
13%

Phase Distribution

2

Early Stage

0

Mid Stage

9

Late Stage

Phase Distribution13 total trials
Early Phase 1First-in-human
1(7.7%)
Phase 1Safety & dosage
1(7.7%)
Phase 3Large-scale testing
2(15.4%)
Phase 4Post-market surveillance
7(53.8%)
N/ANon-phased studies
2(15.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

3

trials recruiting

Total Trials

16

all time

Status Distribution
Active(4)
Completed(6)
Terminated(1)
Other(5)

Detailed Status

Completed6
unknown5
Recruiting3
Not yet recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
16
Active
3
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (7.7%)
Phase 11 (7.7%)
Phase 32 (15.4%)
Phase 47 (53.8%)
N/A2 (15.4%)

Trials by Status

completed638%
unknown531%
not_yet_recruiting16%
terminated16%
recruiting319%

Recent Activity

3 active trials
Showing 5 of 16
recruitingphase_4

Therapeutic Options for CRAB

NCT06440304
recruiting

Use of Fosfomycin in the Treatment of Bacterial Infections

NCT06814899
not_yet_recruitingphase_4

COMPARISON OF NITROFURANTOIN WITH FOSFOMYCIN in TREATING CYSTITIS IN WOMEN

NCT06518291
recruitingphase_3

Fosfomycin Versus Standard of Care in Children With Antibiotic-resistant Urinary Tract Infections

NCT05709028
completednot_applicable

Single Dose Monurol for Treatment of Acute Cystitis

NCT00976963
View all 16 trials

Clinical Trials (16)

Showing 16 of 16 trials
NCT06440304Phase 4

Therapeutic Options for CRAB

Recruiting
NCT06814899

Use of Fosfomycin in the Treatment of Bacterial Infections

Recruiting
NCT06518291Phase 4

COMPARISON OF NITROFURANTOIN WITH FOSFOMYCIN in TREATING CYSTITIS IN WOMEN

Not Yet Recruiting
NCT05709028Phase 3

Fosfomycin Versus Standard of Care in Children With Antibiotic-resistant Urinary Tract Infections

Recruiting
NCT00976963Not Applicable

Single Dose Monurol for Treatment of Acute Cystitis

Completed
NCT03228108Phase 4

Culture-guided Antimicrobial Prophylaxis in Men Undergoing Prostate Biopsy.

Completed
NCT05254808Phase 3

EXtended Use of FOsfomycin for the Treatment of CYstitis in Primary Care

Terminated
NCT05260554

Effect of Cranberry Extract on the Urinary System

Completed
NCT05211011Phase 4

Efficacy and Safety of Intravenous Fosfomycin in Prosthetic Joint Infection

Unknown
NCT05055544Not Applicable

Bearberry in the Treatment of Cystitis

Unknown
NCT03151603Phase 4

Reducing Antibiotic Use for Uncomplicated Urinary Tract Infection in General Practice by Treatment With Uva Ursi (UU)- a Comparative Effectiveness Trial

Completed
NCT03176563

Observational Follow-up Study of REGATTA

Completed
NCT02570074Phase 1

PK/PD and Safety/Tolerability of Two Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adults

Completed
NCT03950544Early Phase 1

The Combined Antibiotic Therapy for Carbapenem Resistant Klebsiella Pneumoniae

Unknown
NCT03260010Phase 4

Efficacy and Safety of Intravenous Fosfomycin in Prosthetic Joint Infection

Unknown
NCT01966653Phase 4

Study Comparing Nitrofurantoin to Fosfomycin for Acute Urinary Tract Infection in Women

Unknown

All 16 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
16